Additionally, although DPP-4 inhibitors are less likely to cause hypoglycemia [19], the risk of hypoglycemia with DPP-4 inhibitor use in patients with DM1, where hypoglycemia is observed even in untreated cases, has not yet been clarified. The gene discussed is DPP4; the disease is Hypoglycemia.